Unique Fabricating, Inc.: Nasdaq/NYSE listing notice — UFAB gets NYSE American extension to March 31, 2024 to file late reports; sale process continues

Unique Fabricating, Inc.

NYSE American granted extension through March 31, 2024 to cure delinquent 10-K (FY2022) and 10-Qs (Q1, Q2 2023).
Company pursuing strategic alternatives, including sale of business, with milestone completion deadline of October 31, 2023.
No assurances given that UFAB will regain compliance or maintain NYSE listing.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Unique Fabricating, Inc. received a nyse_american extension granted notice regarding late filing (rules 134, 1101, 1007).

Exchange: nyse american
Notice: extension granted
Deficiency: late filing
Rules: 134, 1101, 1007

Exact text from the filing

October 3, 2023, the NYSE American granted an extension through March 31, 2024 for the Company to cure its filing deficiency. Pursuant to Section 1007 of the Company Guide, an issuer is required to submit an extension request when it is unable to cure the filing deficiency within the initial six-month period of the maximum 12-month cure period from when it became delinquent. A company’s common stock will continue to be listed and traded on the NYSE during the cure periods, subject to a company’s compliance with other continued listing requirements. The current noncompliance with the NYSE listi

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001617669-23-000039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.